Literature DB >> 28766192

Iron metabolism and drug resistance in cancer.

Hasan Huseyin Kazan1, Cagri Urfali-Mamatoglu2, Ufuk Gunduz2.   

Abstract

Iron is an essential inorganic element for various cellular events. It is directly associated with cell proliferation and growth; therefore, it is expected that iron metabolism is altered in tumor cells which usually have rapid growth rates. The studies on iron metabolism of tumor cells have shown that tumor cells necessitated higher concentrations of iron and the genes of iron uptake proteins were highly over-expressed. However, there are limited number of studies on overall iron metabolism in drug-resistant tumor cells. In this article, we evaluated the studies reporting the relationship between drug resistance and iron metabolism and the utilization of this knowledge for the reversal of drug resistance. Also, the studies on iron-related cell death mechanism, ferroptosis, and its relation to drug resistance were reviewed. We focus on the importance of iron metabolism in drug-resistant cancer cells and how alterations in iron metabolism participate in drug-resistant phenotype.

Entities:  

Keywords:  Chemotherapy; Drug resistance; Ferroptosis; Iron metabolism

Mesh:

Substances:

Year:  2017        PMID: 28766192     DOI: 10.1007/s10534-017-0037-7

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  20 in total

Review 1.  Research progress on the occurrence and therapeutic mechanism of ferroptosis in NSCLC.

Authors:  Yifan Zhang; Ruixue Guo; Jia Li; Liangming Zhu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-11-15       Impact factor: 3.000

2.  Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.

Authors:  Fei-Cheng Yang; Chuan Wang; Jiang Zhu; Qu-Jing Gai; Min Mao; Jiang He; Yan Qin; Xiao-Xue Yao; Yan-Xia Wang; Hui-Min Lu; Mian-Fu Cao; Ming-Min He; Xian-Mei Wen; Ping Leng; Xiong-Wei Cai; Xiao-Hong Yao; Xiu-Wu Bian; Yan Wang
Journal:  Lab Invest       Date:  2022-03-28       Impact factor: 5.662

3.  Hepcidin as a prognostic biomarker in clear cell renal cell carcinoma.

Authors:  Zijian Zhou; Jiajin Wu; Yuanyuan Yang; Peng Gao; Lujia Wang; Zhong Wu
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

Review 4.  Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer.

Authors:  Ruixue Yang; Mei Yi; Bo Xiang
Journal:  Front Cell Dev Biol       Date:  2022-05-13

5.  Glutathione Peroxidase 4 as a Therapeutic Target for Anti-Colorectal Cancer Drug-Tolerant Persister Cells.

Authors:  Xiaoli Zhang; Yiming Ma; Jianhui Ma; Lan Yang; Qingzhi Song; Hongying Wang; Guoqing Lv
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

Review 6.  Transferrin receptor 1 in cancer: a new sight for cancer therapy.

Authors:  Ying Shen; Xin Li; Dandan Dong; Bin Zhang; Yanru Xue; Peng Shang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

7.  Recombinant human lactoferrin induces apoptosis, disruption of F-actin structure and cell cycle arrest with selective cytotoxicity on human triple negative breast cancer cells.

Authors:  Blanca F Iglesias-Figueroa; Tania S Siqueiros-Cendón; Denisse A Gutierrez; Renato J Aguilera; Edward A Espinoza-Sánchez; Sigifredo Arévalo-Gallegos; Armando Varela-Ramirez; Quintín Rascón-Cruz
Journal:  Apoptosis       Date:  2019-08       Impact factor: 4.677

8.  The Role and Underlying Mechanism of Exosomal CA1 in Chemotherapy Resistance in Diffuse Large B Cell Lymphoma.

Authors:  Yuhua Feng; Meizuo Zhong; Youhong Tang; Xianling Liu; Yiping Liu; Leyuan Wang; Hui Zhou
Journal:  Mol Ther Nucleic Acids       Date:  2020-06-24       Impact factor: 8.886

9.  Ribonucleotide Reductase Inhibitor 3-AP Induces Oncogenic Virus Infected Cell Death and Represses Tumor Growth.

Authors:  Lu Dai; Jungang Chen; Yueyu Cao; Luis Del Valle; Zhiqiang Qin
Journal:  J Cancer       Date:  2018-10-31       Impact factor: 4.207

10.  Expression of transferrin receptor-1 (TFR-1) in canine osteosarcomas.

Authors:  Gionata De Vico; Manuela Martano; Paola Maiolino; Francesca Carella; Leonardo Leonardi
Journal:  Vet Med Sci       Date:  2020-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.